Skip to main content
SpringerLink
Log in

High taxane costs driving cytostatic costs in Sweden

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

High taxane costs driving cytostatic costs in Sweden. Pharmacoecon. Outcomes News 317, 12 (2001). https://doi.org/10.1007/BF03269409

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03269409

Keywords

Search

Navigation